The OCMX™ is pleased to announce the listing of ViaTechMD to its online portal which offers Investors and Advisors the ability to learn more about this exciting opportunity.

SCOTTSDALE, AZ, August 02, 2021 /24-7PressRelease/ — ViaTechMD operates as a capital efficient virtual company, partnering with world-class advisory, clinical, regulatory, product development and manufacturing, and physician affiliates. The Company has raised approximately $3.7 million in equity capital from ‘friends and family’ and seeks an additional $8.0 million. This new capital is expected to fund the Company to an exit, and will allow execution of upcoming clinical activities. The Company has expectations of achieving FDA market allowance by Q3 of 2023.

ViaTechMD is also working to establish strategic relationships with large medical device companies to either distribute the CSD or acquire the Company. ViaTechMD is currently organized as a Limited Liability Company under the laws of the State of Delaware and operates its principal place of business in Scottsdale, Arizona.

The OCMX™ is pleased to announce the listing of ViaTechMD to its online portal which offers Investors and Advisors the ability to learn more about this exciting opportunity.

The OCMX™ has spent considerable time completing its due diligence on ViaTechMD and concluded that there is indeed a tremendous potential for this opportunity.

The OCMX™ noted that ViaTechMD exhibits the main components of any solid opportunity, namely a solid management team, a great track record, and a number of key competitive advantages.

Where They Are Headed

ViaTechMD is headed for a very large exit, by way of licensing or an outright sale of its technology to one of a number of very large medical device companies that have shown interest in the company’s globally patented Cervical Stabilization Device.


• Critically important unmet need addressing a growing global healthcare crisis
• First in market and virtually competition free
• Promises to become the Standard of Care
• 5-year Total Addressable Market exceeds $240B
• Promising FDA negotiations


Benjamin V. Booher, Sr., Founding Member & President
Benjamin is the inventor of our device and brings over 46 years of experience in design, engineering and development of materials, technologies and products. Ben designed, built, and lab tested our initial device prototypes, including those prepared and utilized in our first and very successful human fitment studies from 2016 – 2017.

Julie Causey, Company Member & Executive Vice President
Julie is Chairman emeritus of Western Bank and on the Board of Directors of Fairview Health Services and the Board of Trustees of Minnesota Public Radio. Julie served on the Board of Directors of the $30B Federal Reserve Bank of Minneapolis, the Board of Trustees of Colby College, and the Board of Directors and as Audit and Finance Committee Chair for the HealthEast Care System.

Teresa A. Murray, PhD, Company Member & Scientific Advisor
Teresa received her PhD in Bioengineering from Arizona State University, to then become a Postdoctoral Associate at Yale University, and now holds the position of Edmondson/Crump Endowed Associate Professor for Biomedical Research and Rehabilitation Science, at Louisiana Tech University. Dr. Murray was a recipient of the highly competitive National Science Foundation “NSF” Graduate Research Fellowship and two NSF IGERT Fellowships and has 20 years of research experience and biomedical engineering design.

Maximillian D. Fiore, Company Member & Business Advisor
As the Chief Product Development and Operations Officer at NxThera, Inc. Maximillian was key in transforming the company from an R&D startup into a highly successful commercial entity, which sold its technology to Boston Scientific for a reported $408M. Max drove innovation, internal R&D and M&A activities at American Medical Systems leading to the sale of AMS to Endo Pharmaceuticals in 2011 for $2.9B, and is currently on the advisory board of the Biomedical Engineering Department at the University of Minnesota.


The OCMX™ is changing how companies generate exposure in the financial marketplace and raise funds as we know it. The OCMX™ serves both public and private companies in need of market exposure during financial raises. It does this by way of connecting the relevant companies with financial institutions all in one online transparent portal. The OCMX™ (P2P Financial Inc.) launched in September of 2009 out of Toronto but has since expanded its operations to include Quebec, Alberta, Manitoba, and British Columbia.

The OCMX™ connects investors and advisors directly with companies seeking to raise funds or gain broad market exposure. The OCMX™ provides an open venue for innovative growth companies and leading investment funds to generate market awareness, raise funds, or connect with investors and advisors. The OCMX™ provides companies, funds, investors, and advisors instant access to its Online Portal so that they can actively source and connect with their next opportunity, advisor, investor, client, or financing partner.

Contact Us
TD Canada Trust Tower
161 Bay Street, 45th Floor
Toronto, Ontario, M5J 2S1
Tel: 1-866-209-6862
Email: [email protected]

ViaTechMD gets listed on THE OCMX™

For the original version of this press release, please visit here